Trisalus Life Sciences, Inc. · NASDAQ:TLSI
Szela Mary T received 3,990 Trisalus Life Sciences, Inc. shares as an award (Form 4)
Traded Jun 30, 2026 · Filed Jul 1, 2026
On Jun 30, 2026, Szela Mary T (Director, CEO and President) received 3,990 Trisalus Life Sciences, Inc. shares as an award at US$3.87 for US$15,441, leaving 1,077,683 shares. Filed Jul 1, 2026 (Form 4).
- Awarded
- 3,990 shares
- Price
- US$3.87
- Value
- US$15,441
- Holding after
- 1,077,683 shares
- Trading plan
- No
- Role
- Director, CEO and President
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | Common Stock | Award | 3,990 | US$3.87 | 1,077,683 | Direct |
Source
Related
- Trisalus Life Sciences, Inc.
- Szela Mary T
- Trisalus Life Sciences, Inc. shareholders
- Form 4 · Szela Mary T · Oct 7, 2026
- Form 5 · Szela Mary T · Jul 1, 2026
- Form 4 · Szela Mary T · May 18, 2026
- Form 4 · Cox Bryan F. · Oct 7, 2026
- Form 4 · Marshak Richard · Oct 7, 2026
- Form 4 · Stevens Jennifer · Oct 7, 2026
- Schedule 13G/A · First Light Asset Management, LLC · Jul 7, 2026
- Form 4 · Patience David · Jul 6, 2026